You may also see Wolfram Syndrome referred to by its acronym DIDMOAD, which stands for its four hallmark features: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness. What sets it apart from most of what’s covered here is exactly where the eye damage begins — not with the rod and cone photoreceptors at all, but with the optic nerve, the cable transmitting visual signals to the brain, which wears down slowly over the years.
Families reaching us from Rwanda for the eye-related side of Wolfram Syndrome generally arrive after diabetes mellitus has already been diagnosed and is under an endocrinologist’s care, with a new change in vision prompting a referral to confirm optic atrophy and assess how far it has progressed.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
”
Not really — while both cause progressive vision loss, Wolfram Syndrome works through the optic nerve, whereas retinitis pigmentosa affects the rod and cone photoreceptors. That difference shows up both in how vision is lost and in how we go about testing for each.”
”
It’s certainly worth raising with a specialist, especially if the diabetes began at a young age and hearing changes have also come up, though confirming it properly needs OCT imaging of the optic nerve alongside genetic testing, since several other conditions can also cause vision loss in someone with diabetes.”
“Our involvement stays limited to the optic nerve and visual component. Diabetes and hearing loss need to continue under the care of endocrinology and audiology specialists, and we shape our plan to sit alongside whatever they’re already providing.”
“It differs by patient, but optic atrophy in Wolfram Syndrome usually advances gradually over a period of years. Since the mechanism is fundamentally different from rod-cone or cone-rod dystrophies, we monitor it using optic-nerve-specific tests rather than the field and night-vision assessments used for photoreceptor diseases.”
